Roche Taps Lilly Executive Garraway as Chief Medical Officer

                                                                                          Issue # 3006 | August 20th, 2019      





Advertisement














Advertisement














Advertisement
















Advertisement














Advertisement














Advertisement














Advertisement














Advertisement















Advertisement

News Alert



Roche Taps Lilly Executive Garraway as Chief Medical Officer

Roche this week named Eli Lilly executive Levi Garraway to succeed Sandra Horning as chief medical officer and head of global product development. Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target research, will take up the post as of October 1st and be based in South San Francisco. Horning, who joined Genentech nearly a decade ago and has been chief medical officer since 2014, will retire as of the end of 2019. She led the product development organization, oversaw late-stage clinical development, and was co-chair of the committee that invests in pivotal trials. Learn More




Sarepta Duchenne Drug Rejected by FDA in Surprise Setback

In an unexpected decision, the US FDA rejected Sarepta Therapeutics' experimental drug for Duchenne muscular dystrophy, issuing a Complete Response Letter to the rare disease biotech this week. According to Sarepta, the agency cited in its refusal the infection risk tied to the drug's delivery as well as preclinical signs of kidney toxicity. Called Vyondys 53, the medicine is designed for roughly 8% of Duchenne patients with a specific genetic mutation. Approval of the drug was widely anticipated, making the rejection a setback in Sarepta's ambitions to treat a wider pool of Duchenne patients. Learn More




Book Alleging Breaches in Indian Pharma Industry Sparks Debate

Seen as a source of affordable and quality generic medicine for the world, India's pharmaceutical industry has found its credibility questioned by a new book alleging widespread violation of established manufacturing norms by its companies, leading to the production of medicines that potentially risk patients' lives. Bottle Of Lies - Ranbaxy And The Dark Side Of Indian Pharma, by American investigative journalist Katherine Eban, lays bare instances of cooked-up and plagiarised data, the presence of impurities and foreign particles, and unsanitary manufacturing conditions, among other egregious violations. Learn More

Advertisement
Quote Alert


On this Day Alert

1920   Professional Football is Born


On this day in 1920, seven men, including legendary all-around athlete and football star Jim Thorpe, met to organize a professional football league at the Jordan and Hupmobile Auto Showroom in Canton, Ohio. The meeting led to the creation of the American Professional Football Conference (APFC), the forerunner to the successful National Football League. Learn More

Advertisement
TED Alert

How AI Can Save Our Humanity


AI is massively transforming our world, but there's one thing it cannot do: love. In a visionary talk, computer scientist Kai-Fu Lee details how the US and China are driving a deep learning revolution -- and shares a blueprint for how humans can thrive in the age of AI by harnessing compassion and creativity. "AI is serendipity," Lee says. "It is here to liberate us from routine jobs, and it is here to remind us what it is that makes us human." Learn More

Poll Alert

Do you support the US buying Greenland?

Yes
No